Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

The Association of Hif-1α Expression with Primary Resistance to Azacytidine in Patients with High Risk MDS — Preliminary Data of the Hellenic MDS Study Group

Vassiliki Mpakou, PhD, Aris Spathis, PhD, Anthi Bouhla, MD, Konstantinos Gkodopoulos, MD, Georgia Stavroulaki, MD, Irene Glezou, MD, Sotirios Papageorgiou, MD PhD, Efthimia Bazani, MD, Diamantina Vasilatou, MD, Nora Viniou, MD, Athanasios Galanopoulos, MD PhD, Kalliopi Zafeiropoulou, Kotsianidis Ioannis, Argiris Symeonidis, MD PhD, George Dimitriadis, MD, Vassiliki Pappa, MD

Blood (2017) 130 (Supplement 1): 3825.

https://doi.org/10.1182/blood.V130.Suppl_1.3825.3825

Published: 2017

Journal Articles

Apoptosis Induction and Cell Cycle Profiling after Treatment with Low-Dose Decitabine and/or Bortezomib in the AML Cell Line Kasumi-1

Vassiliki Mpakou, PhD, Aris Spathis, PhD, Athanassios Velentzas, PhD, Frieda Kontsioti, PhD, Anthi Bouhla, MD, Konstantinos Gkodopoulos, MD, Georgia Stavroulaki, MD, Irene Glezou, MD, Sotirios Papageorgiou, MD PhD, Efthimia Bazani, MD, Diamantina Vasilatou, MD, Argiris Symeonidis, MD PhD, George Dimitriadis, MD, Vassiliki Pappa, MD

Blood (2017) 130 (Supplement 1): 4994.

https://doi.org/10.1182/blood.V130.Suppl_1.4994.4994

Published: 2017

Journal Articles

Ruxolitinib Remains Effective in Myelofibrosis after the Necessary Dose Reductions: Real-Life Data from a Multi-Center Observational Study

Blood (2016) 128 (22): 5476.

https://doi.org/10.1182/blood.V128.22.5476.5476

Published: 2016

Journal Articles

Apoptosis Induction in Cutaneous T-Cell Lymphoma Cells after Treatment with Lenalidomide

Vassiliki Bakou, Evangelia Papadavid, Aris Spathis, Frieda Kontsioti, Sotiris Papageorgiou, Efthimia Bazani, Diamantina Vasilatou, Konstantinos Gkontopoulos, Georgia Stavroulaki, Irene Glezou, Petros Karakitsos, Dimitrios Rigopoulos, George Dimitriadis, Vassiliki Pappa, MD PhD

Blood (2016) 128 (22): 5303.

https://doi.org/10.1182/blood.V128.22.5303.5303

Published: 2016

Journal Articles

Ruxolitinib Efficacy and Safety in Myelofibrosis: A Multicenter Observational Study

Damianos Sotiropoulos, Vassilios Papadopoulos, Maria Dimou, Despoina Kyriakou, George Papaioannou, George Karavalakis, Emmanuel Papadakis, Maria Palasopoulou, Anastasia Banti, Taxiarchis Kourelis, Alexandra Kouraklis, Theodoros Marinakis, Nora-Athina Viniou, Eleftheria Hatzimichael, Diamantina Vasilatou, George Vassilopoulos, MDPhD, Panayiotis Panayiotidis, Achilles Anagnostopoulos

Blood (2015) 126 (23): 5192.

https://doi.org/10.1182/blood.V126.23.5192.5192

Published: 2015

Journal Articles

Quantitative and Qualitative Analysis of Regulatory T Cells (Tregs) in B Cell Chronic Lymphocytic Leukemia (B-CLL)

Blood (2015) 126 (23): 2928.

https://doi.org/10.1182/blood.V126.23.2928.2928

Published: 2015

Journal Articles

Bortezomib and Methotrexate Interfere with the DNA Repair Signaling Transduction Pathways and Induce Apoptosis in Cutaneous T-Cell Lymphoma

Vassiliki Mpakou, Evangelia Papadavid, Evi Konsta, Vikentiou Murofora, Frieda Kontsioti, Sotiris Papageorgiou, Dikea-Eleni Ioannidou, MD, Eleni Bazani, Christina Economopoulou, MD, Diamantina Vasilatou, Maria Atta, MD, Nikos Papanikolaou, Christoforos Roubakis, Panagiotis Tsirigotis, MD, Christina Antoniou, Dimitris Rigopoulos, George Dimitriadis, Vassiliki Pappa, MD

Blood (2014) 124 (21): 5232.

https://doi.org/10.1182/blood.V124.21.5232.5232

Published: 2014

Journal Articles

Serum Cytokine Profile in Patients with Septic Shock/Severe Sepsis and Thrombocytopenia

Panagiotis Tsirigotis, MD, Konstantinos Gkirkas, MD, Spiros Chondropoulos, MD, Ioannis Papassotiriou, PhD, Anastasia Bartzeliotou, PhD, Christina Economopoulou, MD, Maria Atta, MD, Nikolaos Papanikolaou, MD, Dikea-Eleni Ioannidou, MD, Diamantina Vasilatou, MD, Sotirios G Papageorgiou, MD, Maria Stamouli, MD, Vassiliki Pappa, MD, Ioanna Dimopoulou, MD

Blood (2014) 124 (21): 1426.

https://doi.org/10.1182/blood.V124.21.1426.1426

Published: 2014

Journal Articles

Let-7a, Mir-17 and Mir-20a Expression Levels in CD34+ Bone Marrow Cells of Patients with Myelodysplastic Syndromes (MDS) Are Associated with Established Prognostic Factors, Supporting Their Implication in the Pathogenesis of the Disease,

Christos K Kontos, Vassiliki Pappa, Diamantina Vasilatou, Maria-Angeliki S Pavlou, Frida Kontsioti, Sotirios G Papageorgiou, Panayoula Tsiotra, Christina Economopoulou, Vassiliki Bakou, Efstathios Papageorgiou, Theofanis Economopoulos, John Dervenoulas

Blood (2011) 118 (21): 3792.

https://doi.org/10.1182/blood.V118.21.3792.3792

Published: 2011

NARROW

The Association of Hif-1α Expression with Primary Resistance to Azacytidine in Patients with High Risk MDS — Preliminary Data of the Hellenic MDS Study Group

Apoptosis Induction and Cell Cycle Profiling after Treatment with Low-Dose Decitabine and/or Bortezomib in the AML Cell Line Kasumi-1

Ruxolitinib Remains Effective in Myelofibrosis after the Necessary Dose Reductions: Real-Life Data from a Multi-Center Observational Study

Apoptosis Induction in Cutaneous T-Cell Lymphoma Cells after Treatment with Lenalidomide

Ruxolitinib Efficacy and Safety in Myelofibrosis: A Multicenter Observational Study

Quantitative and Qualitative Analysis of Regulatory T Cells (Tregs) in B Cell Chronic Lymphocytic Leukemia (B-CLL)

Bortezomib and Methotrexate Interfere with the DNA Repair Signaling Transduction Pathways and Induce Apoptosis in Cutaneous T-Cell Lymphoma

Serum Cytokine Profile in Patients with Septic Shock/Severe Sepsis and Thrombocytopenia

Let-7a, Mir-17 and Mir-20a Expression Levels in CD34+ Bone Marrow Cells of Patients with Myelodysplastic Syndromes (MDS) Are Associated with Established Prognostic Factors, Supporting Their Implication in the Pathogenesis of the Disease,

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only